ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Aug 5, 2013
Dividend Increases for the Week Ending August 2 Included Illinois Tool Works and Union Pacific
Let's take a look at the dividend increases for the week ending August 2.
Aug 5, 2013
Which Sectors Are Leading the Market Higher? And Why Is This Important?
Identifying sector and industry leadership is very important for the institutional money manager as doing so often leads to undervalued firms that are just starting to have their value recognized by the market — Valuentum stocks. Let’s dig into which sectors have been strong and which ones have been weak so far in 2013.
Aug 2, 2013
Valuentum's August Edition of Its Dividend Growth Newsletter
The August edition of our Dividend Growth Newsletter is now available.
Aug 1, 2013
Teva Boasts a Several Billion Dollar NTE Opportunity
Revenue potential from the launch of new therapeutic entities (NTEs) in coming years should more than offset troubles from the loss of exclusivity of Copaxone.
Aug 1, 2013
Regulatory Uncertainty Once Again Strikes Visa and MasterCard
Last time regulatory uncertainty struck it provided a wonderful entry point for Visa. Will history repeat itself?
Aug 1, 2013
Pfizer and Merck Show Revenue Declines; Pipelines Remain Strong
Pfizer and Merck faced key patent expirations in the second quarter. However, both of their respective pipelines are promising.
Aug 1, 2013
Newmont Suffers from Weak Gold Prices; Underscores Industry Troubles
Newmont Mining is working to reduce costs, but revenue is falling at a slightly faster pace.
Jul 31, 2013
With North America Saturated, Coach Needs International Growth
Coach’s core North American business isn’t growing as quickly as it used to as competitors catch up.
Jul 30, 2013
American Capital Agency Loses $2.37 Per Share in Second Quarter
American Capital Agency succumbs to wider spreads in the broader mortgage backed securities market. We’re not deceived by the elevated yields in the mortgage REIT space, and we remain on the sidelines as we have been since the industry peak in September 2012.
Jul 29, 2013
AbbVie’s Humira Continues to Drive Strong Performance; Pipeline Advances
Humira continues to drive strong performance in the second quarter, while AbbVie's pipeline advances.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.